ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

Sharon Murphy To Head New Research Center in San Antonio

August 2, 2002

In Brief: XIIIth Congress Draws Record Number Of Abstracts, 3,000 Registrants So Far; Exhibit Area Sold Out

March 5, 1982

NIH Seeks Method For Allocating Research Funds, Determine Economic Impact By Disease Category

April 26, 1974

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986

Nexavar Approved For Patients With Inoperable Liver Cancer

November 30, 2007